| Dr Margo Renee Girardi, MD | |
|
1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110-1003 | |
| (314) 362-1700 | |
| (314) 362-9878 |
| Full Name | Dr Margo Renee Girardi |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 1 Barnes Jewish Hospital Plz, Saint Louis, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104000363 | NPI | - | NPPES |
| 209516103 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2011039548 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington University | 9830008770 | 2506 |
News Archive
The U.S. Department of Health and Human Services today announced the release of more than $1.84 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.
Emergency care covers a range of services that span the care provided by laypersons at the scene, pre-hospital care by SCDF's Emergency Medical Services, to the medical care provided in a dedicated trauma facility - between these stages lie the transportation systems, health centres and first-level hospitals that respond to the emergency.
It's important to identify and treat osteoporosis following hip fracture, but a large study found low rates of assessment and treatment in postmenopausal women who had suffered a hip fracture.
Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
› Verified 6 days ago
| Entity Name | Washington University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746903 PECOS PAC ID: 9830008770 Enrollment ID: O20031119000372 |
News Archive
The U.S. Department of Health and Human Services today announced the release of more than $1.84 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.
Emergency care covers a range of services that span the care provided by laypersons at the scene, pre-hospital care by SCDF's Emergency Medical Services, to the medical care provided in a dedicated trauma facility - between these stages lie the transportation systems, health centres and first-level hospitals that respond to the emergency.
It's important to identify and treat osteoporosis following hip fracture, but a large study found low rates of assessment and treatment in postmenopausal women who had suffered a hip fracture.
Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Margo Renee Girardi, MD Po Box 60352, Saint Louis, MO 63160-0352 Ph: (314) 362-1700 | Dr Margo Renee Girardi, MD 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110-1003 Ph: (314) 362-1700 |
News Archive
The U.S. Department of Health and Human Services today announced the release of more than $1.84 billion to ensure that people living with HIV/AIDS continue to have access to life-saving health care and medications.
Emergency care covers a range of services that span the care provided by laypersons at the scene, pre-hospital care by SCDF's Emergency Medical Services, to the medical care provided in a dedicated trauma facility - between these stages lie the transportation systems, health centres and first-level hospitals that respond to the emergency.
It's important to identify and treat osteoporosis following hip fracture, but a large study found low rates of assessment and treatment in postmenopausal women who had suffered a hip fracture.
Investigators discover cellular mechanisms that may impact the decline of both innate and adaptive immune functions that increase the susceptibility to various infectious agents, cancer and diseases in the elderly say experts at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis' breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva's Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.
› Verified 6 days ago
Dr. Robert Shi-heng Young, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Sumera Younus, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3009 N Ballas Rd Ste 387c, Saint Louis, MO 63131 Phone: 314-996-5900 | |
Dr. James Matthew Freer, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Rachel Hannah Bardowell, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Jabon L Ellis, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1201 S Grand Blvd, Saint Louis, MO 63104 Phone: 314-257-8222 Fax: 915-742-2653 | |
Dr. Patrick Hodge White, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Div Im Hospitalist, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 | |
Dr. Jeffrey B Friesen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 Phone: 314-362-1700 Fax: 314-362-9878 |